NIH-funded research R01 grant

Investigating how certain peptides form nanopores in cell membranes

Official title: Structure and Function of Direct Delivery Peptides

Funded at Tulane University of Louisiana · NIH-10915615 · Data updated 2026-11-12

This study is looking at special tiny openings made by peptides that can help deliver medications directly into cells, which could lead to better treatments for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startSeptember 1, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$378,938
NIH project number5R01GM151326-02
Project IDNIH-10915615 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated with improved drug delivery systems.

Less likely to help

Patients with conditions that do not involve membrane-related drug delivery issues may not receive any benefit from this research.

What this research studies

This research explores the unique behavior of self-assembled peptide nanopores that create large openings in cell membranes. By examining how these peptides interact with lipids and water, the study aims to uncover new principles of peptide and protein assembly in biological membranes. The approach involves testing various peptide structures to understand their stability and function, which could lead to innovative applications in drug delivery and biotechnology. Patients may benefit from advancements in therapies that utilize these nanopores for targeted medication delivery.

Why it matters

Potential benefit: If successful, this research could lead to new methods for delivering medications directly into cells more effectively.

How similar studies have gone: While the concept of peptide nanopores is being explored, this specific approach to understanding their stability and function is relatively novel and has not been extensively tested.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Wimley, William C — Tulane University of Louisiana
  • Study coordinator: Wimley, William C

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.